Aprio Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.62M Buy
10,430
+125
+1% +$26.9K 0.13% 119
2026
Q1
$2.24M Sell
10,305
-159
-2% -$35.3K 0.12% 114
2025
Q4
$2.39M Buy
10,464
+4,502
+76% +$1.03M 0.14% 106
2025
Q3
$1.38M Buy
5,962
+655
+12% +$133K 0.14% 101
2025
Q2
$985K Sell
5,307
-717
-12% -$133K 0.11% 110
2025
Q1
$1.26M Buy
6,024
+517
+9% +$101K 0.16% 87
2024
Q4
$979K Buy
5,507
+301
+6% +$55.3K 0.14% 87
2024
Q3
$1.03M Buy
5,206
+1,265
+32% +$236K 0.16% 78
2024
Q2
$676K Sell
3,941
-3
-0.1% -$497 0.12% 96
2024
Q1
$718K Buy
3,944
+1,136
+40% +$196K 0.14% 84
2023
Q4
$435K Sell
2,808
-652
-19% -$95.1K 0.1% 102
2023
Q3
$516K Buy
+3,460
New +$508K 0.14% 79
2023
Q2
Sell
-1,697
Closed -$271K 153
2023
Q1
$271K Buy
1,697
+160
+10% +$24.5K 0.08% 109
2022
Q4
$248K Buy
+1,537
New +$236K 0.09% 100
2022
Q3
Sell
-1,954
Closed -$299K 110
2022
Q2
$299K Buy
+1,954
New +$299K 0.12% 71

Other funds holding ABBV

Aprio Wealth Management's ABBV Position: Q2 2026 in Review

Aprio Wealth Management increased its AbbVie (ABBV) stake by 1.2% in Q2 2026, buying an estimated $26.9K and bringing the position to 10,430 shares worth $2.62M. The position accounts for 0.13% of the portfolio, ranked #119.

Aprio Wealth Management first reported a position in ABBV in Q2 2022 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aprio Wealth Management held 10,430 shares of AbbVie worth $2.62M as of Q2 2026.
  • Aprio Wealth Management bought 125 AbbVie shares in Q2 2026, an estimated $26.9K.
  • AbbVie made up 0.13% of Aprio Wealth Management's portfolio in Q2 2026, its #119 holding.
  • Aprio Wealth Management first reported a position in AbbVie in Q2 2022 and has held it in 15 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aprio Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.